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Comparison of mortality attributable to tobacco in selected 
Latin American countries 
Mortalidad atribuible al consumo de tabaco en países seleccionados de 
América Latina 
Laura Débora Acosta1, Florencia Molinatti2, & Enrique Peláez3 
 
⎯ RESUMEN: Objetivo: Comparar la mortalidad atribuible al consumo de tabaco en países seleccionados de 
América Latina (Argentina, Brasil, Chile y México) entre los años 2009 y 2013. Método: Se utiliza la metodología 
de Evaluación Comparativa de Riesgos (CRA) para estimar la mortalidad atribuible; luego se calculó los años de 
esperanza de vida perdidos (AEVP), siguiendo la metodología propuesta de Arriaga. Se utilizaron datos 
secundarios de la agencia nacional de estadísticas de cada país. Resultados: Los mayores porcentajes de muerte 
por tabaco se observaron entre los hombres argentinos y chilenos (14,4 y 14,3 % del total de muertes, 
respectivamente), seguidos por los mexicanos (12,5 % del total de muertes). Entre las mujeres, el mayor 
porcentaje se registró en Chile (8 % del total de muertes), seguido por México y Argentina (5,3, y 5,1 % del total de 
muertes, respectivamente). Para ambos sexos, Brasil registró los menores porcentajes (5,4 y 2,8 % del total de 
muertes, para hombres y mujeres). En términos de esperanza de vida, los más afectados por la mortalidad debido 
al consumo de tabaco fueron los hombres y las mujeres de Argentina, quienes perdieron 1,77 y 0,65 años de 
esperanza de vida, respectivamente, seguidos muy de cerca por los hombres y mujeres chilenas. Conclusiones: 
Los hombres y mujeres de Argentina presentaron la mayor pérdida de años de vida a causa del tabaco. Este 
hecho concuerda con la incipiente implementación de la política antitabaco en este país. En cambio, en los otros 
países estudiados las políticas de control han sido implementadas más tempranamente. Sin embargo, el tabaco 
sigue siendo una importante causa de mortalidad en todos estos países, a pesar de los grandes esfuerzos para 
reducir su consumo. 
 
⎯ Palabras Clave: Enfermedades No transmisibles- Mortalidad- Tabaco – Salud Pública – América Latina 
 
⎯ ABSTRACT: Objective: To compare the mortality attributable to tobacco consumption in selected Latin American 
countries (Argentina, Brazil, Chile, and Mexico) between the years 2009 and 2013. Methods: In order to estimate 
the mortality attributable to risk factors, the Comparative Risk Assessment (CRA) methodology was used. Years of 
Life Expectancy Lost (YLEL) were calculated following the methodology proposed by Arriaga. Secondary data from 
the national statistics agency of each country were used. Results: The highest percentages of all deaths due 
tobacco were observed among Argentinian and Chilean men (14.4 and 14.3% of the total deaths, respectively), 
followed by Mexicans (12.5% of the total deaths). Among women, the highest percentage was registered in Chile 
(8% of total deaths), followed by Mexico and Argentina (5.3, and 5.1% of total deaths, respectively). For both sexes, 
Brazil recorded the lowest percentages (5.4 and 2.8% of the total deaths, for men and women). In terms of life 
expectancy, the most affected by mortality due to tobacco consumption were the men and women of Argentina, 
who lost 1.77 and 0.65 years of life expectancy, respectively, followed very closely by the Chilean men and women. 
Conclusions: Men and women of Argentina had the greatest loss of life expectancy due to tobacco; this is 
consistent with the incipient policy against tobacco implemented in that country. In contrast, in the other countries 
studied, tobacco control policies were implemented earlier. However, tobacco remains an important cause of 
mortality in all these countries, despite the great efforts to reduce its consumption. 
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Preventable risk factors are the basis of most non-communicable diseases (NCD) 
such as cancer, diabetes mellitus, cardiovascular diseases, chronic respiratory 
diseases, and external causes. Risk factors such as smoking, physical inactivity, an 
unhealthy diet, and harmful alcohol use are responsible for a large part of the global 
burden of morbidity and mortality, either directly or through conditions such as 
hypertension, hyperglycemia, and hypercholesterolemia (World Health Organization 
[WHO], 2016). 
Particularly, tobacco use is associated with disabilities and NCD deaths: cancers, 
especially lung cancer, cardiovascular disease, and diseases of the respiratory 
system (Öberg, Jaakkola Maritta, Woodward, Peruga, & Prüss-Ustün, 2011). 
According to World Health Organization (2013) data, tobacco kills up to half of its 
consumers, about 6 million people, more than 5 million of whom are consumers of 
the product and more than 600 000 are non-smokers exposed to other people’s 
smoke. Almost 80% of the world's 1 billion smokers live in low- or middle-income 
countries. It is the leading cause of worldwide preventable death. 
Nearly 70 million smokers in Latin America are at risk of tobacco-related death and 
disease, according with The Tobacco Atlas, Sixth Edition (American Cancer Society, 
2016). For example, smoking is the single most important cancer risk factor and 
accounts for 26% of all cancer deaths and 84% of lung cancer deaths in Latin 
America (Yamaguchi et al., 2017). While the proportion of the population who use 
tobacco has nearly halved across the region thanks to strong tobacco control policies 
in some countries, the region is seeing an increase in tobacco-related deaths, to 
more than 300 000 in 2016 (American Cancer Society, 2016). 
To reduce the public health threat of tobacco use, the WHO has promoted the 
ratification of the WHO Framework Convention on Tobacco Control (FCTC) and 
developed demand reduction tools to help countries reduce tobacco use. 
Specifically, the “MPOWER” package advocates the following evidence-
based strategies: Monitor tobacco use and prevention policies; Protect 
people from tobacco smoke; Offer help to quit tobacco use; Warn about the 
dangers of tobacco; Enforce bans on tobacco advertising, promotion, and 
sponsorship; and Raise taxes on tobacco. (Ahluwalia, Arrazola, & 
Graffunder, 2017, p.10) 
Argentina, Chile, Cuba, and Uruguay have the highest smoking prevalence in Latin 
American-Caribbean countries and, in the last ten years, the impact of smoking 
meant the loss of between two and six years in life expectancy among men 50 years 
and over (Palloni, Novak, & Pinto-Aguirre, 2015). In these countries, the level of 
implementation of MPOWER package has not been homogeneous, but most of them 
(Argentine, Chile, Brazil, and Uruguay) implemented four to six strategies (Blanco, 
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Raising tobacco taxes to make these deadly products unaffordable is the most cost-
effective measure to reduce tobacco use or to prevent its initiation among youth. 
Argentina and Chile are the only countries in Latin America that have taxes on 
tobacco products of at least 80% of the retail price. In contrast, in Brazil and Mexico 
the share of total taxes in the retail price does not reach 70% but the cigarettes are 
less affordable since 2008 (World Health Organization, 2017). 
Based on this background, the goal of this study is to compare the mortality 
attributable to tobacco use, in selected Latin American countries (Argentina, Brazil, 






This study compared the differences in mortality attributable to tobacco use4 in 
Argentina, Brazil, Chile, and Mexico, by using official secondary data. The data on the 
smoking prevalence (Pi) were obtained from several surveys carried out in the 
countries studied: 
⎯ Argentina. Encuesta Nacional de Factores de Riesgo (ENFR) 2013 [2013 
National Survey of Risk Factors], 
⎯ Brazil. Pesquisa Nacional de Saúde (PNS) 2013 [2013 National Health 
Survey], 
⎯ Chile. Encuesta Nacional de Salud (ENS) 2009-2010 [2009-2010 National 
Health Survey], and 
⎯ Mexico. Encuesta Nacional de Salud y Nutrición (ENSANUT) 2012 [2012 
National Health and Nutrition Survey]. 
 
The Relative Risks (RR) corresponding to each cause of death related to tobacco use 
were obtained from meta-analyses (United States Department of Health and Human 
Services, 2014), as established by the Comparative Risk Assessment (CRA) 
methodology. 
 
                                                          
4 Tobacco use was classified in three categories: 1) Smoker: the person who has smoked at least 100 
cigarettes in his or her lifetime and currently smokes all or some days, 2) Former-smoker: the smoker 
who no longer smokes; and 3) person who has never smoked is the person who has never smoked or 
smoked less than 100 cigarettes in their entire life. Exception: Considering that the Brazilian National 
Health Survey did not inquire whether the person had smoked 100 or more cigarettes in their lifetime, a 
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Mortality observed (MO) and population data were obtained from public-use microdata 
files and statistical yearbooks prepared by the national agencies responsible for their 
registration: 
1. Argentina. Ministerio de Salud de la Nación, Dirección de Estadísticas e 
Investigación en Salud (MSAL-DEIS) 2012-2014 
2. Brazil. Ministério de Saúde do Brasil. Sistema de Informações sobre 
Mortalidade (MS-SIM) 2012-2014 
3. Chile. Ministerio de Salud de Chile, Departamento de Estadísticas e 
Información de Salud (MINSAL-DEIS) 2009-2011, and 
4. Mexico. Secretaría de Salud de México. Sistema Nacional de Información en 
Salud (SSA-SINAIS) 2011-2013). 
The quality and internal consistency of the databases were evaluated. According to 
the latest report on health statistics of the World Health Organization (2014b), the four 
countries analyzed have a mortality registry coverage of more than 90% and the 
proportion of deaths without registration of sex or age is less than 2%; these were 
imputed according to the distribution of the valid data. 
The calculations of mortality attributable (MA) and Years of Life Expectancy Lost 
(YLEL) were performed using the Epidat (2016) software: a piece of software for 
epidemiological data analysis, Version 4.2. 
2.2. Attributable Risk Calculation 
To estimate the mortality attributable to tobacco, the Comparative Risk Assessment 
methodology [CRA] (Ezzati et al., 2006) was used. The CRA methodology is based on 
the fact that the contribution of a risk factor to mortality can be estimated by means of 
the Population Attributable Fraction (PAF), comparing the burden due to the exposure 
observed in the population with a hypothetical distribution. This hypothetical 
distribution is defined as a counterfactual scenario (Mathers, Vos, Lopez, Salomon, & 
Ezzati, 2001). The PAF formula for discrete variables tobacco use with n exposure 
levels is (see equation 1): 









      (equation 1) 
 
where n is the number of exposure categories or levels, Pi the prevalence of the 
exposure category (prevalence of smoking prevalence obtained from several surveys 
carried out), RRi is the relative risk in the exposure category (United States 
Department of Health and Human Services, 2014), and P´i the prevalence of exposure 
in the counterfactual scenario.  
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Then, MO due to tobacco use was multiplied by the attributable fraction obtained and 
the MA to tobacco use was obtained (see equation 2). 
 𝑀𝐴 = 𝑀𝑂 × 𝑃𝐴𝐹 (equation 2) 
2.3. Years of Life Expectancy Lost Calculation 
Once the attributable deaths were estimated, the YLEL were calculated following the 
methodology proposed by Arriaga (2014). The method of calculation of the YLEL is 
based on the life tables and allows adjustment by age structure of the population. 
Unlike other methods, such as the Years of Potential Life Lost (YPLL) developed by 
Pan American Health Organization, or the Healthy Life Years (HLY) index, the YLEL 
index is not affected by the age structure of the population. YLEL were calculated 
between ages 35 and 80. These age limits were used for two reasons: first, because 
the RRs estimated in the meta-analyses were estimated as of 35 years; second, 







Argentina, Brazil, and Mexico had a prevalence of smoking among men higher than 
20% and lower than 30%, while Chile is 37.7 % (see table 1). In the case of Chilean 
women, a smoking prevalence of 33% stands out. Argentina and Brazil had a 
prevalence among women lower than 20%, and Mexican women had the lowest 
prevalence (8.7%).  
Table 1   
Argentina, Brazil, Chile and Mexico, 2009-2013: Prevalence of smokers, 
former smokers and people who never smoked for the adult population 
aged 35 and over, by gender and age group 
Age group Tobacco use 
Argentina 2013 Brazil 2013 Chile 2009-10 Mexico 2012 
Men Women Men Women Men Women Men Women 
35 to 64 
years 
Smokers 30.6 22.7 21.9 14.9 42.6 37.6 30.2 9.6 
Former 
smokers 
23.3 16.7 23.8 17.5 30.0 21.4 26.4 10.2 
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46.1 60.6 54.3 67.6 27.4 41.1 43.5 80.2 
Aged 65 
and over 
Smokers 12.4 10.4 13.9 7.1 11.8 14.4 17.1 4.5 
Former 
smokers 
44.3 17.3 45.7 20.7 42.2 22.2 45.2 13.5 
Never 
smoked 
43.3 72.3 40.4 72.2 46.0 63.4 37.7 82.0 
Total 
population 
aged  35 
and over 
Smokers 26.7 19.3 20.4 13.3 37.7 33.0 27.9 8.7 
Former 
smokers 
27.8 16.8 27.9 18.2 32.0 21.5 29.7 10.8 
Never 
smoked 
45.5 63.9 51.7 68.5 30.4 45.5 42.5 80.5 
Source: Argentina: ENFR 2013 / Brazil: PNS 2013 / Chile: ENS 2009-10 / Mexico: ENSANUT 2012. Own research with 
Epidat (2016) 4.2 
 
In the case of people over 65, both Brazilian and Mexican men had the highest 
prevalence among smokers and former smokers, covering approximately 60% of the 
population of that age, followed by Argentinian and Chilean men. In the case of 
women, Mexican women were the smokers (both current and past) who smoke the 
least, with a prevalence of 18%. 
In the case of the 35-64 age group, the trend was quite different: Chilean men had the 
highest prevalence, more than 72% of the population of that age (including smokers 
and ex-smokers). In the second place were the Chilean women, with a prevalence 
close to 59%. Among women, less than 40% of Argentinian women smoked at least 
once in their lifetime and that percentage was lower among Brazilian women, less than 
33%. 
Regarding the weight of the deaths attributable to tobacco in the general mortality of 
the country, it was observed that among Argentinian and Chilean men, smoking 
deaths accounted for just over 14% of the total. Among women, the highest 
percentage of all deaths due to tobacco was recorded in Chile (8%) (see table 2). 
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Table 2   
Argentina, Brazil, Chile and Mexico, 2009-2013: Mortality attributable to 





Argentina 2013 Brazil 2013 Chile 2009-10 Mexico 2012 
Men Women Men Women Men Women Men Women 
Malignant 
neoplasms 
9,195 2,916 29,028 9,800 2,843 1,223 7,316 2,180 
Cardiovascu
lar diseases 
7,890 2,626 29,267 12,877 2,260 1,101 13,479 3,779 
Respiratory 
diseases 




21,865 7,430 92,347 40,581 6,614 3,360 35,511 12,481 
All deaths 151,969 146,779 1,701,410 1,426,386 46,353 41,970 278,393 235,543 
Percentage 
of all deaths 
attributable 
to tobacco 
14.4 5.1 5.4 2.8 14.3 8.0 12.6 5.3 
Source: Argentina: ENFR 2013. MSAL-DEIS, 2012-2014 / Brazil: IBGE - PNS 2013. MS-SIM, 2012-2014 / Chile: ENS 
2009-10. MINSAL-DEIS, 2009-2011 / Mexico: ENSANUT 2012. SSA-SINAIS, 2011-2013. Own research with Epidat 
(2016) 4.2 
Performing a simple cause analysis, it could be observed that among men and women 
in Argentina and Chile, the main cause of death attributable to smoking was cancer of 
the trachea, lung or bronchus. In Brazil and Mexico, however, others chronic 
obstructive pulmonary diseases (COPD) were the leading cause of death (see table 
3in the end of article). 
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When analyzing the impact that these prevalence had on mortality using the YLEL 
methodology (see table 4), it could be observed that the most affected by mortality due 
to tobacco use were Argentinian men, who lost 1.77 years of life expectancy, followed 
by the Chilean men who lost 1.28 years of life expectancy. Mexican men lost 0.95 
years of life expectancy, and Brazilian men had the lowest loss of years (0.65). Among 
women, the greatest loss of years of life expectancy was recorded in Argentinian 
women (0.65), followed by Chilean (0.53); Mexican women loss 0.31 years and 
Brazilian women had the lowest loss of years of life expectancy (0.28). 
Table 4 
Argentina, Brazil, Chile and Mexico, 2009-2013: Comparison of YLEL attributable 
to tobacco use in adults aged 35 and over, by gender and groups of causes of 
death 
Groups of causes of 
death 
Argentina 2013 Brazil 2013 Chile 2009-10 Mexico 2012 
Men Women Men Women Men Women Men Women 
Malignant neoplasms 0.82 0.28 0.25 0.09 0.59 0.23 0.25 0.08 
Cardiovascular diseases 0.69 0.24 0.27 0.12 0.53 0.23 0.49 0.12 
Respiratory diseases 0.26 0.12 0.13 0.07 0.16 0.08 0.21 0.10 
Total causes attributable 
to tobacco use 1.77 0.65 0.65 0.28 1.28 0.53 0.95 0.31 
Other causes not 
attributable to tobacco 
use 5.82 4.07 7.39 4.70 4.76 3.05 6.59 4.64 
Total YLEL 7.59 4.72 8.04 4.99 6.04 3.58 7.53 4.95 
Source: Argentina: ENFR 2013. MSAL-DEIS, 2012-2014 / Brazil: IBGE - PNS 2013. MS-SIM, 2012-2014 / Chile: 
ENS 2009-10. MINSAL-DEIS, 2009-2011 / Mexico: ENSANUT 2012. SSA-SINAIS, 2011-2013. Own research with 
Epidat (2016) 4.2 
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The objective of this study was to compare the mortality attributable to tobacco use in 
selected Latin American countries between the years 2009 and 2013. We found that, 
between males, the most affected groups by mortality due to tobacco use were 
Argentinian men and, between females, were Argentinian women.  
Differences in the level of mortality attributable to tobacco between the countries 
studied could be explained by the prevalence of tobacco use and the prevalence and 
incidence of NCD in each population. The first issue is related to the policies of 
prevention and promotion of health, and the second issue is associated with the health 
system in each country, in addition to epidemiologic transition and population aging in 
the countries studied.  
Although the highest prevalence of tobacco use was recorded in Chile, both among 
men and women, the greatest loss of years of life expectancy was observed in 
Argentina. In the same way, although Mexico and Argentina have close smoking 
prevalence (slightly over 25% of men aged 35 and over currently smoke), the 
proportion of deaths attributable to this factor is higher in Argentina (14.4% versus 
12.6%); and Mexican men lose less years of life expectancy (1.77 versus 0.95). The 
factors that can explain these facts could be found in the daily number of cigarettes 
smoked, the average age of the onset of smoking, the age at which former smokers 
quitted, among others.  
In addition, highest loss of years of life expectancy observed in Argentina could be 
explained by policies applied against tobacco, related specially with protecting people 
from tobacco smoke. In this sense, in Chile, like Brazil and Mexico, the highest level of 
application of the MPOWER package was achieved, particularly in relation to tobacco 
monitoring and the application of control policies, and health warnings about tobacco 
hazards between three and six years earlier than in Argentina (Organización 
Panamericana de la Salud [OPS], 2016). Brazil, along with Uruguay and Panama, has 
been a continental leader in tobacco control; it has implemented progressively 
stronger tobacco control policies to more than halve smoking prevalence since 1980. 
In Argentina smoking rates are falling, but the country has yet ratify the WHO FCTC, 
and cigarettes are extremely affordable (Burki, 2017). In fact, in the group of 65 years 
and more the prevalence of ex-smokers in both sexes in almost every country is 
almost double that of smokers. What would be reflecting success in awareness are 
campaigns to stop smoking, combined with the abandonment of habit due to health 
complications.  
 
Another explanation is related to incidence and treatment of illness associated to 
tobacco, and health system in each country. In Argentina and Chile, the main cause is 
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rate of 49% (American Cancer Society, 2016), in Mexico and Brazil, it is the COPD, 
with a 5-year survival rate of 74% (Solanes & Casan, 2010). 
Compared with figures from other countries, it is observed that, while Brazil and 
Mexico have an incidence of deaths caused by tobacco use lower than other 
countries, Argentina and Chile show values similar to those recorded in Spain 
(Gutiérrez-Abejón et al., 2015) and Uruguay (Sandoya & Bianco, 2011) and slightly 
higher than those observed in Paraguay (Sánchez & San Martín, 2010).  
Estimates of the number of deaths attributable to tobacco use are lower than those 
achieved by other studies such as those carried out by the Institute for Clinical 
Effectiveness and Health Policy (IECS) work team (Instituto de Efectividad Clínica y 
Sanitaria [IECS], 2017a, 2017b, 2017c; Pinto et al., 2017), by Argentine Observatory 
on Drugs (Observatorio Argentino de Drogas, 2016), and by Guerrero López, Munos-
Hernandez, Saenz De Miera-Juarez, & Reynales-Shigematsu (2013), particularly in 
Brazil and Mexico. Nevertheless, these differences can be possibly explained by the 
application of different methodologies, the selection of sources of information and the 
incorporation of parameters5. 
This paper has some limitations. One limitation of our study was related to the source 
of data of the Brazilian National Health Survey, because a person who smokes daily or 
occasionally is considered a smoker, and it did not inquire whether the person had 
smoked 100 or more cigarettes in their lifetime, like other sources of data. This fact 
could affect the prevalence of smoking in Brazil.  
Another limitation was related to the quality of mortality data, with an underreporting of 
mortality of about 1% in Chile and of up to 9% in Brazil in 2009. Moreover, wrongly 
defined causes are high in Argentina and Brazil (around 8%) (Comisión Económica 
para América Latina y el Caribe [CEPAL], 2014). In addition, garbage codes are high 
in these countries: in average, in the period 1998-2011 about 22% in Argentina, 21% 
in Brazil, 6% in Mexico and 11% in Chile (World Health Organization, 2013). Both, 
underreporting of mortality and garbage codes could affect the prevalence of mortality 
related to tobacco, especially in Argentina and Brazil. 
Finally, it is important to clarify that tobacco use is just one cause of disease, and non-
communicable diseases are associated with the effects of multiple causes: genetic, 
lifestyle and environmental factors. In this sense, differences in mortality attributable to 
tobacco between these countries could reflect other factors not studied in this paper. 
For example, Mexican women had higher loss of years of life expectancy than 
Brazilian women due to respiratory diseases; despite Brazilian women had a higher 
prevalence of tobacco use than Mexican women. One possible explanation is that 
women in Mexico are more exposed to other risk factors to respiratory diseases (for 
example, occupational and environmental air pollution). 
                                                          
5 For example, to estimate people's probabilities of getting sick or die from each of the conditions associated with 
smoking, IECS used a mathematical model. In all countries the data correspond to 2015 and to people over 35 
years of age (IECS, 2017a, 2017b, 2017c, Pinto et al., 2017). 
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We found that the groups most affected by mortality due to tobacco use were 
Argentinian men and women, and this fact is according to incipient policy against 
tobacco in that country; while in Brazil, México and Chile tobacco policy control was 
implemented early. Despite this, tobacco use is still an important cause of death in 
these countries. The results of this study indicate the importance of considering 
tobacco consumption as a public health issue in these countries. Efforts to reduce 
tobacco use have been significant, but they are far from being sufficient.  
The Political Declaration of the High-level Meeting of the United Nations General 
Assembly on the Prevention and Control of Non-Communicable Diseases, adopted in 
September 2011, recognize that effective non-communicable disease prevention and 
control require leadership and multisectoral approaches for health at the government 
level, including, as appropriate, health in all policies and whole-of-government 
approaches across such sectors as health, education, energy, agriculture, sports, 
transport, communication, urban planning, environment, labour, employment, industry 
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Table 3 
Argentina, Brazil, Chile and Mexico, 2009-2013: Number and percentage of all deaths attributable to tobacco by 
gender and cause of death 
 
Causes of death 
(ICD-10 code) 
Argentina 2013 Brazil 2013 Chile 2009-2010 Mexico 2012 
Men Women Men Women Men Women Men Women 
N % N % N % N % N % N % N % N % 
Malignant neoplasms 9,195 61.2 2,916 32.3 29,028 61.5 9,800 33.1 2,843 49.1 1,223 30.5 7,316 57.4 2,180 17.7 
Lip, oral cavity, pharynx 
(COO-C14) 
454 72.7 90 36.2 4,079 73.3 559 37.4 100 70.4 28 41.9 509 74.7 103 28.6 
Esophagus (C15) 846 69.7 249 42.1 4,302 70.1 848 48.2 280 66.2 120 48.4 526 71.8 85 36.9 
Pancreas (C25) 401 21.3 359 17.3 935 22.0 766 17.9 113 23.0 138 23.0 428 24.7 257 12.8 
Larynx (C32) 561 81.3 69 62.2 2,999 81.8 339 65.1 94 76.8 10 53.6 604 82.5 58 53.0 
Continúa… 
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Causes of death 
(ICD-10 code) 
Argentina 2013 Brazil 2013 Chile 2009-2010 Mexico 2012 
Men Women Men Women Men Women Men Women 
N % N % N % N % N % N % N % N % 
Trachea, lung, bronchus 
(C33-C34) 
5,530 87.1 1,845 63.9 12,736 87.1 6,147 63.8 1,419 85.7 676 68.2 3,682 88.0 1,240 53.0 
Cervix uteri (C53) n/a n/a 114 11.8 n/a n/a 445 9.0 n/a n/a 78 n/a 0 n/a 214 n/a 
rinary bladder (C67) 427 42.8 64 18.0 1,070 44.0 233 20.8 113 40.4 
35 
24.8 308 46.9 51 15.7 
Kidney and renal pelvis 
(C64-C65) 
457 37.1 24 4.2 631 36.8 37 3.7 149 37.1 11 5.1 460 39.6 18 2.5 
Stomach (C16) 473 25.8 89 8.5 2,277 25.8 427 8.8 557 25.4 119 11.0 799 28.0 153 6.1 
Acute myeloid leukemia 
(C92.0) 
46 21.7 13 7.4 /a/ /a/ /a/ /a/ 17 22.9 7 9.4 /a/ /a/ /a/ /a/ 
Cardiovascular 
diseases 
7,890 18.5 2,626 6.1 29,267 21.0 12,877 11.1 2,260 19.7 1,101 10.6 13,479 21.2 3,779 6.5 
Continúa… 
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Causes of death 
(ICD-10 code) 
Argentina 2013 Brazil 2013 Chile 2009-2010 Mexico 2012 
Men Women Men Women Men Women Men Women 
N % N % N % N % N % N % N % N % 
Coronary heart disease 
(I20-I25) 
2,570 21.8 728 8.8 14,256 23.5 5,321 12.1 1,029 23.1 376 12.9 9,229 22.5 2,321 7.1 
Other heart diseases 
(I00-I09, I26-I28, I29-I51) 
3,284 16.0 974 4.0 4,189 18.5 1,402 7.7 389 16.6 187 7.1 1,313 19.2 345 4.3 
Cerebrovascular disease 
(I60-I69) 
1,412 15.6 791 8.2 7,856 15.9 4,887 10.0 634 15.3 
439 
10.1 2,594 17.4 1,023 6.3 
Atherosclerosis (I70) 32 20.1 5 1.6 132 24.6 23 3.4 25 39.9 7 8.8 39 26.8 6 3.2 
Aortic aneurysm (I71) 560 61.0 109 34.2 2,566 62.5 1,062 39.5 162 61.3 76 44.2 215 64.1 39 29.5 
Other arterial disease 
(I72-I78) 
32 11.8 18 7.1 269 13.7 183 9.0 21 12.2 16 9.5 89 15.9 45 6.8 
Respiratory diseases 4,780 34.4 1,887 13.9 33,801 51.7 17,814 31.0 1,510 46.4 1,037 33.5 43,291 217.2 6,522 39.5 
Continúa… 
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Causes of death 
(ICD-10 code) 
Argentina 2013 Brazil 2013 Chile 2009-2010 Mexico 2012 
Men Women Men Women Men Women Men Women 
N % N % N % N % N % N % N % N % 
Influenza, pneumonia 
(J10-J11, J12-J18) 
1,975 19.1 691 5.9 6,182 20.2 2,366 7.4 303 18.3 
  133 
7.5 2,120 28.9 407 6.6 
Bronchitis, emphysema 
(J40-J42, J43) 
186 86.9 87 63.4 2.796 89.3 1,425 72.0 95 84.3 68 75.3 8,296 353.1 1,027 67.0 
Other chronic obstructive 
pulmonary diseases 
(J44) 
2,619 78.4 1,109 59.9 24,823 78.5 14,023 59.9 1,112 74.9 836 67.8 32,875 320.9 5,089 57.5 
TOTAL deaths 
attributable to tobacco 
21,865 30.5 7,430 11.3 92,347 36.5 40,581 19.8 6,614 32.3 3,360 19.3 64,086 66.5 12,481 14.4 
Notes: N: Number of deaths attributable to tobacco; %: Percentage; ICD-10: International Classification of diseases. Tenth version; n/a: not applicable data; /a/ Cause of death excluded 
due to non-availability of the fourth digit in the Sistema de Informações sobre Mortalidade (Brazil). 
Source: Argentina: ENFR 2013. MSAL-DEIS, 2012-2014 / Brazil: IBGE - PNS 2013. MS-SIM, 2012-2014 / Chile: ENS 2009-10. MINSAL-DEIS, 2009-2011 / Mexico: ENSANUT 2012. 
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